Forward P/S Multiple: Inspire Medical Systems, Inc. (INSP)
Inspire Medical Systems (INSP) management's transparent strategy for insurance market penetration defines the trend reflected in the forward price-to-sales valuation chart, where the 4.50 mark serves as a key metric. Capitalization growth is driven by the sale of high-margin implants for the treatment of apnea. Exclusive patents and an extensive network of trained surgeons provide additional stability to the asset, creating a significant barrier to entry for competitors.
Summary analytical data breakdowns for Inspire Medical Systems Inc (INSP)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Inspire Medical Systems|INSP - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Inspire Medical Systems|INSP - Company Aggregate Debts|Debt to Book Capitalization Ratio Inspire Medical Systems Inc|INSP - Company Long-Term Debt|Company Current Liabilities Inspire Medical Systems|Quick Ratio inspiresleep.com
- financial results and valuation multiples details:
INSP - Company Net Income|Expected Profit Inspire Medical Systems|INSP - Market Cap to Net Income Ratio|Projected Price to Earnings Inspire Sleep|INSP - PEG Multiple|EV/EBITDA Multiple Inspire Medical Systems Inc|INSP - Operating income before deduction of amortization|Earnings per share for the last twelve months Inspire Medical Systems|INSP - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months inspiresleep.com|INSP - Net earnings per share growth this year|Earnings growth forecast for next year Inspire Medical Systems
- sales and revenue indicators:
Fundamental company analysis:INSP (Inspire Medical Systems, Inc.)
When constructing a defensive portfolio, it is critical to assess capitalization relative to expected revenue, which allows investors to filter out market noise from genuine fundamental shifts. By analyzing the forward P/S of Inspire Medical Systems (INSP), an investor can see how the efficiency of microelectronics outsourcing impacts the business value, converting operational flexibility into a sustainable market value multiple.
Who Inspire Medical Systems competes with
Price-to-Projected Revenue Ratio Dexcom DXCM|PEN - Forward Price-to-Revenue Multiple|Novanta Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Haemonetics Company|PRCT: Forward P/S Multiple|Market Cap to Projected Revenue CNMD|PLSE (Pulse Biosciences) - Forward P/S Multiple|InMode Ltd (INMD) - Market Cap to Expected Sales Ratio|Forward P/S Multiple PMI|Forward Price-to-Revenue Multiple Surmodics Inc. SRDX|Forward P/S Multiple SENS (Senseonics Holdings)|Forward P/S Multiple neuropace.com NPCE|TCMD - Price-to-Projected Revenue Ratio|SNWV: Price-to-Projected Revenue Ratio|OM (Outset) - Forward Price-to-Revenue Multiple|Electromed - Forward Price to Sales|LNSR (LENSAR, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio avitamedical.com RCEL|Price-to-Projected Revenue Ratio Profound Medical Corp. (PROF)|bairdmed.com (BDMD) - Projected Price to Revenue|EDAP TMS - Forward Price-to-Revenue Multiple|Forward P/S Multiple Apyx Medical Corp APYX|IceCure Medical, Ltd. - Forward P/S Multiple|Market Cap to Expected Sales Ratio Pulmonx Corporation LUNG|telabio.com (TELA) - Price-to-Projected Revenue Ratio|Future Price to Revenue CTSO (CytoSorbents Corporation)|Price-to-Projected Revenue Ratio Sensus Healthcare Corp|Forward Price-to-Revenue Multiple Zynex Corp (ZYXI)|Forward P/S Multiple ECOR|RBOT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Inspira Technologies IINN|ICU: Market Cap to Projected Revenue|IRIX: Forward Price-to-Revenue Multiple|Intelligent Bio Solutions - Price to Expected Revenue Ratio|XAIR: Forward P/S Multiple|PFSA - Market Cap to Expected Sales Ratio|Price-to-Projected Revenue Ratio STRATA Skin Sciences Inc.|Market Cap to Projected Revenue GCTK (glucotrack.com)|Price-to-Projected Revenue Ratio NanoVibronix (NAOV)|Market Cap to Expected Sales Ratio Venus Concept Corporation|Price-to-Projected Revenue Ratio Nuwellis, Inc. NUWE|AEMD (aethlonmedical.com) - Future Price to Revenue|TransEnterix - Forward P/S Multiple|Market Cap to Expected Sales Ratio Avinger Inc. AVGR|BioSig Technologies, Inc (BSGM) - Price-to-Projected Revenue Ratio|Cutera Inc - Forward Price to Sales|KNW (Know Labs, Inc.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio inarimedical.com NARI|Forward Price-to-Revenue Multiple NVRO (Nevro)|RSLS (reshapelifesciences.com) - Forward Price to Sales|Price-to-Projected Revenue Ratio Silk Road Medical Inc. SILK
